Remedy Pharmaceuticals to Showcase Groundbreaking Phase 3 CHARM Study Data on CIRARA® at International Stroke Conference 2025
Hand-out
Press Releases
January 29, 2025

Remedy Pharmaceuticals to Showcase Groundbreaking Phase 3 CHARM Study Data on CIRARA® at International Stroke Conference 2025

NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction (LHI) today announced three speaker presentations of efficacy

bradford

The Bradford Era

More by this Author
Local & Social